Risk factors for severe and critically ill COVID‐19 patients: a review

Y Gao, M Ding, X Dong, J Zhang, A Kursat Azkur… - Allergy, 2021 - Wiley Online Library
The pandemic of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …

Biomarkers in COVID-19: an up-to-date review

M Samprathi, M Jayashree - Frontiers in pediatrics, 2021 - frontiersin.org
The ongoing pandemic of coronavirus disease 2019 (COVID-19) poses several challenges
to clinicians. Timely diagnosis and hospitalization, risk stratification, effective utilization of …

COVID and cardiovascular disease: what we know in 2021

M Chilazi, EY Duffy, A Thakkar, ED Michos - Current atherosclerosis …, 2021 - Springer
Abstract Purpose of Review Coronavirus disease 2019 (COVID-19) has been the cause of
significant global morbidity and mortality. Here, we review the literature to date of the short …

Estimating risk of mechanical ventilation and in-hospital mortality among adult COVID-19 patients admitted to Mass General Brigham: The VICE and DICE scores

CJ Nicholson, L Wooster, HH Sigurslid, RH Li… - …, 2021 - thelancet.com
Background Risk stratification of COVID-19 patients upon hospital admission is key for their
successful treatment and efficient utilization of hospital resources. We sought to evaluate the …

[HTML][HTML] Международный регистр “Анализ динамики Коморбидных заболеваний у пациенТов, перенесшИх инфицироВание SARS-CoV-2”(AКТИВ SARS-CoV …

ГП Арутюнов, ЕИ Тарловская… - Российский …, 2021 - cyberleninka.ru
Международный регистр АКТИВ представляет подробную характеристику
амбулаторных и госпитальных пациентов с COVID-19 евразийского региона. При …

[HTML][HTML] International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors”(AKTIV SARS-CoV-2): analysis of predictors of short-term adverse …

GP Arutyunov, EI Tarlovskaya… - Russian Journal of …, 2021 - russjcardiol.elpub.ru
The international AKTIV register presents a detailed description of out-and inpatients with
COVID-19 in the Eurasian region. It was found that hospitalized patients had more …

[HTML][HTML] Risk factors for COVID-19 progression and mortality in hospitalized patients without pre-existing comorbidities

W Liu, C Yang, YG Liao, F Wan, L Lin, X Huang… - Journal of infection and …, 2022 - Elsevier
Abstract Background Coronavirus disease 2019 (COVID-19) pandemic continues to
escalate intensively worldwide. Massive studies on general populations with SARS-CoV-2 …

Association between antithrombin and mortality in patients with COVID-19. A possible link with obesity

C Gazzaruso, E Paolozzi, C Valenti… - Nutrition, Metabolism …, 2020 - Elsevier
Background and aims Despite anticoagulation, usually with heparin, mortality for
thromboembolic events in COVID-19 remains high. Clinical efficacy of heparin is due to its …

A comparison of XGBoost, random forest, and nomograph for the prediction of disease severity in patients with COVID-19 pneumonia: implications of cytokine and …

W Hong, X Zhou, S Jin, Y Lu, J Pan, Q Lin… - Frontiers in Cellular …, 2022 - frontiersin.org
Background and Aims The aim of this study was to apply machine learning models and a
nomogram to differentiate critically ill from non-critically ill COVID-19 pneumonia patients …

[HTML][HTML] The impact of frailty on COVID-19 outcomes: a systematic review and meta-analysis of 16 cohort studies

Y Yang, K Luo, Y Jiang, Q Yu, X Huang, J Wang… - The Journal of nutrition …, 2021 - Elsevier
Background Frail patients are increasingly vulnerable to stress, which is mainly manifested
by a reduced physiologic reserve in metabolic and immune systems and neuromuscular …